Why Jefferies sees these stocks as standout biotech plays in 2026 Dec 23, 2025 10:00AM
Black Diamond Therapeutics' (BDTX) Phase 2 Silevertinib Data Encouraging - Stifel Dec 4, 2025 07:17AM
Guggenheim Downgrades Black Diamond Therapeutics (BDTX) to Neutral Dec 3, 2025 12:39PM
Stifel Starts Black Diamond Therapeutics (BDTX) at Buy Oct 15, 2025 04:08PM
Freedom Capital Markets Starts Black Diamond Therapeutics (BDTX) at Buy, 'Unlocking the Next Wave in Cancer Therapeutics' Sep 30, 2025 12:18PM


Sep 4, 2025 05:43AM Guggenheim Starts Black Diamond Therapeutics (BDTX) at Buy
Aug 11, 2025 06:40AM Black Diamond Therapeutics (BDTX) PT Lowered to $10 at H.C. Wainwright
Jul 1, 2025 06:24AM Raymond James Resumes Black Diamond Therapeutics (BDTX) at Outperform
May 13, 2025 06:55AM Black Diamond Therapeutics, Inc. (BDTX) Tops Q1 EPS by 93c
Mar 20, 2025 08:32AM Stifel Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
Mar 19, 2025 07:01AM Black Diamond Therapeutics (BDTX), Servier Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy
Mar 18, 2025 06:39AM Black Diamond Therapeutics (BDTX) PT Raised to $12 at H.C. Wainwright
Mar 7, 2025 09:03AM Black Diamond Therapeutics (BDTX) PT Lowered to $15 at Stifel
Mar 6, 2025 05:17PM Black Diamond Therapeutics, Inc. (BDTX) Tops Q4 EPS by 7c
Feb 19, 2025 09:16AM NAYA Biosciences (NAYA) nominates new Board members
Nov 6, 2024 07:32AM Black Diamond Therapeutics (BDTX) PT Lowered to $16 at Stifel
Nov 5, 2024 08:24AM Black Diamond Therapeutics, Inc. (BDTX) Tops Q3 EPS by 9c
Oct 9, 2024 07:21AM H.C. Wainwright Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
Oct 8, 2024 07:39AM Piper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX)
Oct 7, 2024 04:01PM Black Diamond Therapeutics (BDTX) Announces Restructuring Plan to Focus Resources on BDTX-1535 and Extend Cash Runway
Sep 24, 2024 06:48AM H.C. Wainwright Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
Sep 23, 2024 02:19PM TD Cowen Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
Sep 23, 2024 08:18AM Black Diamond (BDTX) Climbs 42% Following Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC
Sep 23, 2024 07:02AM Black Diamond Therapeutics (BDTX) Announces Initial Phase 2 Data Demonstrating Robust Anti-tumor Activity of BDTX-1535 in Patients with Recurrent EGFRm NSCLC
Sep 18, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
Sep 16, 2024 07:49AM Piper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX)
Sep 10, 2024 07:44AM Piper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX)
Aug 8, 2024 04:09PM Gyre Therapeutics (GYRE) Appoints David M. Epstein to its Board
Aug 6, 2024 08:01AM Black Diamond Therapeutics, Inc. (BDTX) Tops Q2 EPS by 3c
Jul 18, 2024 07:51AM Piper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX)
Jul 3, 2024 07:14AM Piper Sandler Reiterates Overweight Rating on Black Diamond Therapeutics (BDTX)